Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

pp60c-src C-terminal phosphoregulatory peptide

Src kinase inhibitor
BML-P301-0001 1 mg 218.00 USD
Do you need bulk/larger quantities?
This phosphopeptideis the C-terminal negative regulatory domain of c-Src (521-533) which includes the negative regulatory site (Tyr527). This peptide, when tyrosine-phosphorylated, binds to the internal SH2 domain.

Product Specification

Alternative Name:[pTyr527] c-Src (521-533)
Appearance:Lyophilized solid.
Solubility:Soluble in Water.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C

Product Literature References

Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis: D. Thompson, et al.; Clin. Sci. (Lond.) 131, 2489 (2017), Abstract;
Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats: P.K. Picardi, et al.; Endocrinology 149, 3870 (2008), Abstract; Full Text
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration: Y. Izawa, et al.; Hypertens. Res. 20, 1107 (2007), Abstract;
Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4): B. Lu, et al.; J. Biol. Chem. 276, 35589 (2001), Abstract;

Product Toolbox


Certificate of Analysis


By target:
Src kinase
By biological activity:
Src kinase Inhibitor
By catalog section:


Technical Service
Customer Service

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,